These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 15957962)

  • 1. Controversies in breast cancer: adjuvant and neoadjuvant therapy.
    Montemurro F; Redana S; Valabrega G; Aglietta M
    Expert Opin Pharmacother; 2005 Jun; 6(7):1055-72. PubMed ID: 15957962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic treatment of patients with early breast cancer: recent updates and state of the art.
    Caparica R; Brandão M; Piccart M
    Breast; 2019 Nov; 48 Suppl 1():S7-S20. PubMed ID: 31839166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overview of resistance to systemic therapy in patients with breast cancer.
    Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
    Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Sensitivity of chemotherapy depending on hormone status in breast cancer].
    Ito Y
    Nihon Rinsho; 2007 Jun; 65 Suppl 6():568-71. PubMed ID: 17679212
    [No Abstract]   [Full Text] [Related]  

  • 5. Using aromatase inhibitors in the neoadjuvant setting: evolution or revolution?
    Freedman OC; Verma S; Clemons MJ
    Cancer Treat Rev; 2005 Feb; 31(1):1-17. PubMed ID: 15707700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neoadjuvant systemic therapy for breast cancer: an overview and review of recent clinical trials.
    Hanrahan EO; Hennessy BT; Valero V
    Expert Opin Pharmacother; 2005 Aug; 6(9):1477-91. PubMed ID: 16086636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Adjuvant treatment of operable breast cancer].
    Khosravi Shahi P; Izarzugaza Perón Y; Encinas García S; Díaz Muñoz de la Espada VM; Pérez Manga G
    An Med Interna; 2008 Jan; 25(1):36-40. PubMed ID: 18377195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selected highlights from the 27th San Antonio Breast Cancer Symposium. San Antonio, TX, USA, 8-11 December 2004.
    Ponzone R; Sismondi P
    Expert Opin Pharmacother; 2005 Jun; 6(7):1257-67. PubMed ID: 15957978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast cancer: achievements in adjuvant systemic therapies in the pre-genomic era.
    Colozza M; de Azambuja E; Cardoso F; Bernard C; Piccart MJ
    Oncologist; 2006 Feb; 11(2):111-25. PubMed ID: 16476832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Role of taxanes in treatment of breast cancer].
    Gorbunova VA; Besova NS
    Vopr Onkol; 2004; 50(4):492-500. PubMed ID: 15605777
    [No Abstract]   [Full Text] [Related]  

  • 11. A systematic overview of chemotherapy effects in breast cancer.
    Bergh J; Jönsson PE; Glimelius B; Nygren P;
    Acta Oncol; 2001; 40(2-3):253-81. PubMed ID: 11441936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging role of taxanes in adjuvant and neoadjuvant therapy for breast cancer: the potential and the questions.
    Goble S; Bear HD
    Surg Clin North Am; 2003 Aug; 83(4):943-71. PubMed ID: 12875604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical significance and pathological evaluation of neoadjuvant chemotherapy in breast cancer].
    Chen LR
    Zhonghua Bing Li Xue Za Zhi; 2010 Apr; 39(4):218-21. PubMed ID: 20654118
    [No Abstract]   [Full Text] [Related]  

  • 14. Progress in systemic adjuvant therapy of early-stage breast cancer.
    Gradishar WJ; O'Regan RM
    Int J Clin Oncol; 2003 Aug; 8(4):239-47. PubMed ID: 12955580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of taxanes in the treatment of breast cancer.
    Nabholtz JM; Gligorov J
    Expert Opin Pharmacother; 2005 Jun; 6(7):1073-94. PubMed ID: 15957963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neoadjuvant endocrine treatment in primary breast cancer - review of literature.
    Mathew J; Asgeirsson KS; Jackson LR; Cheung KL; Robertson JF
    Breast; 2009 Dec; 18(6):339-44. PubMed ID: 19836953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Breast cancer: HER2 changes one's cards on the table].
    Lopez M
    Clin Ter; 2005; 156(5):255-62. PubMed ID: 16382976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neoadjuvant Therapy for HER2-positive Breast Cancer.
    Wuerstlein R; Harbeck N
    Rev Recent Clin Trials; 2017; 12(2):81-92. PubMed ID: 28164759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast cancer: adjuvant modalities.
    Sakr BJ; Dizon DS
    Clin Obstet Gynecol; 2011 Mar; 54(1):150-6. PubMed ID: 21278514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Present state and future prospects: a review of cooperative groups' adjuvant and neoadjuvant trials in breast cancer.
    Mamounas EP
    Clin Breast Cancer; 2001 Oct; 2 Suppl 1():S20-30. PubMed ID: 11970741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.